Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancerHan Wu(Affiliated Hospital of Nantong University), Wei Wang(South China Agricultural University)OncoTargets and TherapySeptember 1, 201610.2147/ott.s105787Cited by 37SaveCiteExport RISWatch citationsRelated PapersEfficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II study|European Journal of Cancer|2024|18[Clinicopathologic characteristics of breast cancer with basal-like immunophenotype].|PubMed|2008|0